These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms. Waddington JL Int Rev Neurobiol; 1989; 31():297-353. PubMed ID: 2574716 [No Abstract] [Full Text] [Related]
8. Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use. Lévy E; Margolese HC; Annable L; Chouinard G Can J Psychiatry; 2004 Jun; 49(6):398-402. PubMed ID: 15283536 [TBL] [Abstract][Full Text] [Related]
9. Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America. Kasper S; Lowry AJ; Hodge A; Bitter I; Dossenbach M Schizophr Res; 2006 Jan; 81(2-3):139-43. PubMed ID: 16253478 [TBL] [Abstract][Full Text] [Related]
10. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. Go CL; Rosales RL; Caraos RJ; Fernandez HH Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort. Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G; J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288 [TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107 [TBL] [Abstract][Full Text] [Related]
13. An assessment of tardive dyskinesia in schizophrenic outpatients. Smith JM; Kucharski LT; Eblen C; Knutsen E; Linn C Psychopharmacology (Berl); 1979 Jun; 64(1):99-104. PubMed ID: 113841 [TBL] [Abstract][Full Text] [Related]
14. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients. Csernansky JG; Kaplan J; Holman CA; Hollister LE Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793 [TBL] [Abstract][Full Text] [Related]
15. An international survey of tardive dyskinesia. Guy W; Ban TA; Wilson WH Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):401-5. PubMed ID: 2866562 [TBL] [Abstract][Full Text] [Related]
16. Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment. Byne W; White L; Parella M; Adams R; Harvey PD; Davis KL Int J Geriatr Psychiatry; 1998 Jul; 13(7):473-9. PubMed ID: 9695037 [TBL] [Abstract][Full Text] [Related]
17. Maintenance ECT in a patient with catatonic schizophrenia and tardive dyskinesia. Uçok A; Uçok G Convuls Ther; 1996 Jun; 12(2):108-12. PubMed ID: 8744171 [TBL] [Abstract][Full Text] [Related]
18. Lack of complaints in schizophrenics with tardive dyskinesia. Alexopoulos GS J Nerv Ment Dis; 1979 Feb; 167(2):125-7. PubMed ID: 33230 [TBL] [Abstract][Full Text] [Related]
19. The prevalence of tardive dyskinesia. Woerner MG; Kane JM; Lieberman JA; Alvir J; Bergmann KJ; Borenstein M; Schooler NR; Mukherjee S; Rotrosen J; Rubinstein M J Clin Psychopharmacol; 1991 Feb; 11(1):34-42. PubMed ID: 1674949 [TBL] [Abstract][Full Text] [Related]
20. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]